RHJA
AXGN icon

Rice Hall James & Associates’s Axogen AXGN Stock Holding History

Rice Hall James & Associates’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41M Sell
73,903
-7,240
-9% -$292K 0.17% 138
2026
Q1 		$2.69M Hold
81,143
– – 0.15% 143
2025
Q4 		$2.66M Sell
81,143
-32,489
-29% -$799K 0.15% 143
2025
Q3 		$2.03M Sell
113,632
-45,709
-29% -$663K 0.11% 159
2025
Q2 		$1.73M Sell
159,341
-29,772
-16% -$390K 0.09% 172
2025
Q1 		$3.5M Sell
189,113
-1,855
-1% -$33.5K 0.21% 108
2024
Q4 		$3.15M Sell
190,968
-1,212
-0.6% -$17.2K 0.17% 132
2024
Q3 		$2.69M Sell
192,180
-2,089
-1% -$23.1K 0.15% 149
2024
Q2 		$1.41M Buy
194,269
+41,095
+27% +$281K 0.08% 191
2024
Q1 		$1.24M Buy
+153,174
New +$1.37M 0.07% 204
2022
Q1 		– Sell
-160,255
Closed -$1.5M – 308
2021
Q4 		$1.5M Sell
160,255
-4,827
-3% -$57.9K 0.05% 227
2021
Q3 		$2.61M Buy
165,082
+63,829
+63% +$1.15M 0.1% 161
2021
Q2 		$2.19M Buy
+101,253
New +$2.05M 0.08% 197

Other funds holding AXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Rice Hall James & Associates's AXGN Position: Q2 2026 in Review

Rice Hall James & Associates reduced its Axogen (AXGN) stake by 8.9% in Q2 2026, selling an estimated $292K and leaving 73,903 shares worth $3.41M. The position accounts for 0.17% of the portfolio, ranked #138.

Rice Hall James & Associates first reported a position in AXGN in Q2 2021 and has held it in 13 quarters since. The position peaked at $3.5M in Q1 2025. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Rice Hall James & Associates held 73,903 shares of Axogen worth $3.41M as of Q2 2026.
  • Rice Hall James & Associates sold 7,240 Axogen shares in Q2 2026, an estimated $292K.
  • Axogen made up 0.17% of Rice Hall James & Associates's portfolio in Q2 2026, its #138 holding.
  • Rice Hall James & Associates first reported a position in Axogen in Q2 2021 and has held it in 13 quarters since.
  • Rice Hall James & Associates's Axogen position peaked at $3.5M in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.